Zobrazeno 1 - 10
of 926
pro vyhledávání: '"James CH"'
Autor:
Peter A van Veelen, Jacques Neefjes, Sjoerd H van der Burg, Thorbald van Hall, Marten Visser, Linda de Bruin, Lukas JAC Hawinkels, James CH Hardwick, Saskia J Santegoets, Tom J Harryvan, Léonie Plug, Lisa Griffioen, Arend Mulder, Gerbrand J van der Heden van Noort, Marlieke LM Jongsma, Miranda H Meeuwsen, Emmanuel JHJ Wiertz, Els ME Verdegaal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background Cross-presentation of exogenous antigens in HLA-class I molecules by professional antigen presenting cells (APCs) is crucial for CD8+ T cell function. Recent murine studies show that several non-professional APCs, including cancer-associat
Externí odkaz:
https://doaj.org/article/445d6f47a6724dfba4c033a139d8a46b
Autor:
Levy, Benjamin P, Felip, Enriqueta, Reck, Martin, Yang, James CH, Cappuzzo, Federico, Yoneshima, Yasuto, Zhou, Caicun, Rawat, Siddhartha, Xie, Jingdong, Basak, Priyanka, Xu, Lu, Sands, Jacob
Publikováno v:
Future Oncology; Jul2023, Vol. 19 Issue 21, p1461-1472, 12p
Publikováno v:
Hong Kong Medical Journal.
Publikováno v:
Interfaces, 2013 Sep 01. 43(5), 462-476.
Externí odkaz:
https://www.jstor.org/stable/43699332
Publikováno v:
In Current Opinion in Pharmacology December 2012 12(6):690-695
Autor:
D Ross Camidge, H. Ryun Kim, M.J. Ahn, James CH. Yang, J.-Y. Han, M.J. Hochmair, K.H. Lee, A. Delmonte, M.R. Garcia Campelo, D.-W. Kim, F. Griesinger, E. Felip, R. Califano, A.I. Spira, M. Thomas, S.N. Gettinger, M. Tiseo, Y. Liu, P. Zhang, S. Popat
Publikováno v:
Journal of Thoracic Oncology. 18:e27
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Armando Santoro, Wu-Chou Su, Alejandro Navarro, Matteo Simonelli, James CH Yang, Andrea Ardizzoni, Fabrice Barlesi, Jin Hyoung Kang, Sarah DiDominick, Ahmed Abdelhady, Xueying Chen, Uz Stammberger, Enriqueta Felip
Publikováno v:
Scientia
LUNG CANCER
LUNG CANCER, 2022, 166, pp.170-177. ⟨10.1016/j.lungcan.2022.02.010⟩
LUNG CANCER
LUNG CANCER, 2022, 166, pp.170-177. ⟨10.1016/j.lungcan.2022.02.010⟩
ALK inhibitors; Ceritinib; Ribociclib Inhibidores de ALK; Ceritinib; Ribociclib Inhibidors d'ALK; Ceritinib; Ribociclib Background Preclinical data show that the combination of an ALK inhibitor (ALKi) with a cyclin-dependent kinase 4/6 inhibitor (CDK
Publikováno v:
BioTechniques, Vol 41, Iss 5, Pp 554-558 (2006)
Externí odkaz:
https://doaj.org/article/7c1b8db7e790426dbf9eb9cb9faec292
Autor:
Dang, Hao, Pelt, Gabi W Van, Haasnoot, Krijn JC, Backes, Yara, Elias, Sjoerd G, Seerden, Tom CJ, Schwartz, Matthijs P, Spanier, Bernhard WM, Cappel, Wouter H De Vos Tot Nederveen, Bergeijk, Jeroen D Van, Kessels, Koen, Geesing, Joost MJ, Groen, John N, Borg, Frank Ter, Wolfhagen, Frank HJ, Seldenrijk, Cornelis A, Raicu, Mihaela G, Milne, Anya N, Lent, Anja UG Van, Brosens, Lodewijk AA, G Johan A Offerhaus, Siersema, Peter D, Tollenaar, Rob AEM, Hardwick, James CH, Hawinkels, Lukas JAC, Moons, Leon MG, Miangela M Lacle, Mesker, Wilma E, Boonstra, Jurjen J
Supplemental material, sj-pdf-1-ueg-10.1177_2050640620975324 for Tumour–stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study by Hao Dang, Gabi W van Pelt, Krijn JC Haasnoot, Yara Backes,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a665107cb25d18bfd20ad53057180e